Small-cap stocks often fly under the radar of institutional investors, yet they can deliver outsized returns for those ...

Boston Scientific (BSX) delivered earnings and revenue surprises of +5.63% and +1.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?